| 000 | 03528 a2200973 4500 | ||
|---|---|---|---|
| 005 | 20250515225645.0 | ||
| 264 | 0 | _c20100817 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1878-3686 | ||
| 024 | 7 |
_a10.1016/j.ccr.2010.04.026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarretero, Julian | |
| 245 | 0 | 0 |
_aIntegrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. _h[electronic resource] |
| 260 |
_bCancer cell _cJun 2010 |
||
| 300 |
_a547-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAMP-Activated Protein Kinase Kinases |
| 650 | 0 | 4 | _aAMP-Activated Protein Kinases |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
| 650 | 0 | 4 |
_aCell Adhesion _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xgenetics |
| 650 | 0 | 4 |
_aCell Transdifferentiation _xgenetics |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFocal Adhesion Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aFocal Adhesions _xgenetics |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xgenetics |
| 650 | 0 | 4 | _aGenomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMAP Kinase Kinase 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMAP Kinase Kinase 2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Mutant Strains |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNeoplasm Metastasis _xdrug therapy |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aPhosphorylation _xgenetics |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProteomics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xgenetics |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
| 650 | 0 | 4 |
_aUp-Regulation _xgenetics |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 |
_aras Proteins _xgenetics |
| 650 | 0 | 4 |
_asrc-Family Kinases _xantagonists & inhibitors |
| 700 | 1 | _aShimamura, Takeshi | |
| 700 | 1 | _aRikova, Klarisa | |
| 700 | 1 | _aJackson, Autumn L | |
| 700 | 1 | _aWilkerson, Matthew D | |
| 700 | 1 | _aBorgman, Christa L | |
| 700 | 1 | _aButtarazzi, Matthew S | |
| 700 | 1 | _aSanofsky, Benjamin A | |
| 700 | 1 | _aMcNamara, Kate L | |
| 700 | 1 | _aBrandstetter, Kathleyn A | |
| 700 | 1 | _aWalton, Zandra E | |
| 700 | 1 | _aGu, Ting-Lei | |
| 700 | 1 | _aSilva, Jeffrey C | |
| 700 | 1 | _aCrosby, Katherine | |
| 700 | 1 | _aShapiro, Geoffrey I | |
| 700 | 1 | _aMaira, Sauveur-Michel | |
| 700 | 1 | _aJi, Hongbin | |
| 700 | 1 | _aCastrillon, Diego H | |
| 700 | 1 | _aKim, Carla F | |
| 700 | 1 | _aGarcía-Echeverría, Carlos | |
| 700 | 1 | _aBardeesy, Nabeel | |
| 700 | 1 | _aSharpless, Norman E | |
| 700 | 1 | _aHayes, Neil D | |
| 700 | 1 | _aKim, William Y | |
| 700 | 1 | _aEngelman, Jeffrey A | |
| 700 | 1 | _aWong, Kwok-Kin | |
| 773 | 0 |
_tCancer cell _gvol. 17 _gno. 6 _gp. 547-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ccr.2010.04.026 _zAvailable from publisher's website |
| 999 |
_c19891479 _d19891479 |
||